內地對外證券投資資產1.42萬億美元 在港投資額6,101億美元
國家外匯管理局公佈2024年末內地對外證券投資資產分國家/地區及分居民持有者部門數據顯示,內地對外證券投資資產(不包括含儲備資產)1.42萬億美元(下同)。其中,股權類投資8,598億元,債券類投資5,575億元。
資產分佈在首五位的國家/地區爲中國香港、美國、開曼羣島、英屬維爾京羣島和英國,投資金額分別爲6,101億元、3,316億元、1,156億元、720億元和360億元。
期內,內地持有對外證券資產的部門主要是非銀行金融機構、銀行和非金融部門,投資金額分別爲7,955億元、4,221億元和1,998億元,佔內地對外證券投資總額的56%、30%和14%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.